75
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Genetic toxicology and preliminary in vivo studies of nitric oxide donor tocopherol analogs as potential new class of antiatherogenic agents

, , , , , , , , , , , & show all
Pages 285-293 | Received 15 Jul 2010, Accepted 17 Sep 2010, Published online: 07 Jun 2011

References

  • Ames, B. N., McCann, J., Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347–364.
  • Andreassi, M. G., Picano, E., Del Ry, S., Botto, N., Colombo, M. G., Giannessi, D., et al. (2001). Chronic long-term nitrate therapy: possible cytogenetic effect in humans? Mutagenesis 16:517–521.
  • Azqueta, A., Pachón, G., Cascante, M., Creppy, E. E., López de Cerain, A. (2007). A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment. Chem Biol Interact 168:95–105.
  • Balbo, S., Lazzarato, L., Di Stilo, A., Fruttero, R., Lombaert, N., Kirsch-Volders, M. (2008). Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water-soluble analogue of CHF 2363. Toxicol Lett 178:44–51.
  • Beckman, J. S., Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424–C1437.
  • Berliner, J. A., Heinecke, J. W. (1996). The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707–727.
  • Brown, G. C. (1995). Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369:136–139.
  • Cerecetto, H., López, G. V. (2007). Antioxidants derived from vitamin E: an overview. Mini Rev Med Chem 7:315–338.
  • Chang, J., Rao, N. V., Markewitz, J. R., Hoidal, J. R., Micahel, J. R. (1996). Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. Am J Physiol 270:L931–L940.
  • Chu, K. C., Patel, K. M., Lin, A. H., Tarone, R. E., Linhart, M. S., Dunkel, V. C. (1981). Evaluating statistical analysis and reproducibilitiy of microbial mutagenicity assays. Mutat Res 85:119–132.
  • Collins, A. R., Dusinska, M., Franklin, M., Somorovska, M., Petrovska, H., Fillion, L., et al. (1997). Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mut 30:139–146.
  • Denicola, A., Batthyány, C., Lissi, E., Freeman, B. A., Rubbo, H., Radi, R. (2002). Diffusion of nitric oxide into low density lipoprotein. J Biol Chem 277:932–936.
  • Gross, S. S., Wolin, M. S. (1995). Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57:737–769.
  • Kim, Y. M., Bergonia, H., Lancaster, J. R. J. (1995). Nitrogen oxide–induced autoprotection in isolated rat hepatocytes. FEBS Lett 374:228–232.
  • Lee, D. H., Pfeifer, G. P. (2007). Mutagenesis induced by the nitric oxide donor, sodium nitroprusside, in mouse cells. Mutagenesis 22:63–67.
  • Lin, W., Xue, H., Liu, S., He, Y., Fu, J., Zhou, Z. (1998). Genotoxicity of nitric oxide produced from sodium nitroprusside. Mutat Res 413:121–127.
  • Liu, R. H., Hotchkiss, J. H. (1995). Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 339:73–89.
  • López, G. V., Batthyány, C., Blanco, F., Botti, H., Trostchansky, A., Migliaro, E., et al. (2005). Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide–releasing tocopherol analogs. Bioorg Med Chem 13:5787–5796.
  • López, G. V., Blanco, F., Hernández, P., Ferreira, A., Piro, O. E., Batthyány, C., et al. (2007). Second generation of α-tocopherol analogs-nitric oxide donors: synthesis, physicochemical, and biological characterization. Bioorg Med Chem 15:6262–6272.
  • López, G. V., Gómez, L. E., Campillo, N., Páez, J. A., Giles, K., Atkinson, J., et al. (2009). Interaction studies between human alpha-tocopherol transfer protein and nitric oxide donor tocopherol analogues with LDL-protective activity. Bioorg Med Chem 17:8143–8148.
  • Maron, D. M., Ames, B. N. (1983). Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215.
  • Möller, M., Botti, H., Batthyány, C., Rubbo, H., Radi, R., Denicola, A. (2005). Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein. J Biol Chem 280:8850–8854.
  • Monastyrskaya, E., Folarin, N., Malyshev, I., Green, C., Andreeva, L. (2002). Application of the nitric oxide donor, SNAP, to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 7:127–131.
  • Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., Tannenbaum, R. (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 89:3030–3034.
  • Richter, C., Gogvadze, V., Schlapbach, R., Schweizer, M., Schlegel, J. (1994). Nitric oxide kills hepatocytes by mobilizing mitochondrial calcium. Biochem Biophys Res Commun 205:1143–1150.
  • Ross, R. (1992). Atherogenesis. In: Gallin, J. I., Goldstein, I. M., Snyderman, R. (Eds.), Inflammation: basic principles and clinical correlates, 2nd ed. (pp 1051–1059). New York: Raven Press.
  • Rubbo, H., Radi, R., Anselmi, D., Kirk, M., Barnes, S., Butler, J., et al. (2000). Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation. Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate. J Biol Chem 275:10812–10818.
  • Sandhu, J. K., Birnboim, H. C. (1997). Mutagenicity and cytotoxicity of reactive oxygen and nitrogen species in the MN-11 murine tumor cell line. Mutat Res 379:241–252.
  • Schoen, F. J. (1994). Blood vessels. In: Cotran, R. S., Kumar, V., Robbins, S. L. (Eds.), Robbins pathologic basis of disease, 5th ed. (pp 489–499). Philadelphia, Pennsylvania, USA: WB Saunders.
  • Schweizer, M., Richter, C. (1994). Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 204:169–175.
  • Sorba, G., Medana, C., Fruttero, R., Cena, C., Di Stilo, A., Galli, U., et al. (1997). Water-soluble furoxan derivatives as NO prodrugs. J Med Chem 40:463–469.
  • Wink, D. A., Kasprzak, C. M., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., et al. (1991). DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001–1003.

References

  • Boschi, D., Di Stilo, A., Cena, C., Lolli, M., Fruttero, R., Gasco, A. (1997). Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities. Pharm Res 14:1750–1758.
  • Gibson, Q. H., Roughton, F. J. (1957). The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 136:507–526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.